AI MARKET SCANNING

$INO

Inovio Pharmaceuticals Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Pharmaceuticals Major
AVG HISTORICAL GAP0.72%
MAX GAP RECORD-6.98%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $INO

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.2%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $INO

AI REPORT
Aug 24

Sector Analysis: The Pulse of the Market

Analysis Market dynamics remain volatile as sector-specific developments influence broader financial trends. This analysis dives into key sectors…
VIEW REPORT_
AI REPORT
Aug 18

Daily Champions: Decoding Bearish Signals in the Market

Analysis Markets are currently grappling with a wave of bearish signals, as evidenced by the top-performing assets showing…
VIEW REPORT_
AI REPORT
Jul 27

Weekly Market Recap: Mixed Signals and Retail Weakness

Analysis Markets this week delivered a mixed bag of signals, with significant moves in both equities and commodities.…
VIEW REPORT_